Common Contracts
3 similar Credit Agreement contracts by Clarient, Inc
ContractCredit Agreement • May 5th, 2020 • Pennsylvania
alter, affect, release or prejudice in any way any of Borrowers’ obligations under the Credit Agreement (including, without limitation, the Obligations), each of which are ratified and confirmed This Amendment shall not obligate Lender to provide any further consent to any waiver or modification of any other term or condition of the Credit Agreement or prejudice any right or remedy that Lender may now or hereafter have under or in connection with the Credit Agreement. This consent shall not be construed as a course of conduct on the part of Lender upon which Borrowers may rely at any time in the future. Borrowers expressly waive any right to assert any claim to such effect at any time. 2. Joinder. (a) Upon the effectiveness of this Amendment, Joining Borrower joins in as, assumes the obligations and liabilities of, adopts the obligations, liabilities and role of, and becomes, a Borrower under the Loan Documents, the Amended and Restated Revolving Note and all other Loan Documents. All
FOURTH AMENDMENT AND JOINDER TO CREDIT AGREEMENTCredit Agreement • March 16th, 2010 • Clarient, Inc • Services-medical laboratories • Pennsylvania
This Fourth Amendment and Joinder to Credit Agreement (“Amendment”) is made as of this 21st day of December, 2009, by and among Gemino Healthcare Finance, LLC (“Lender”) and Clarient, Inc., Clarient Diagnostic Services, Inc. and ChromaVision International, Inc. (collectively, the “Existing Borrowers”) and Applied Genomics, Inc. (“Joining Borrower” and together with the Existing Borrowers, the “Borrowers” and each individually referred to as a “Borrower”).
FOURTH AMENDMENT AND JOINDER TO CREDIT AGREEMENTCredit Agreement • December 23rd, 2009 • Clarient, Inc • Services-medical laboratories • Pennsylvania
This Fourth Amendment and Joinder to Credit Agreement (“Amendment”) is made as of this 21st day of December, 2009, by and among Gemino Healthcare Finance, LLC (“Lender”) and Clarient, Inc., Clarient Diagnostic Services, Inc. and ChromaVision International, Inc. (collectively, the “Existing Borrowers”) and Applied Genomics, Inc. (“Joining Borrower” and together with the Existing Borrowers, the “Borrowers” and each individually referred to as a “Borrower”).
